|
News for CombiMatrix Corporation
(CBMX)
|
|
|
|
After Hours:
$ 3.3166
|
-0.0034 (-0.10%)
|
Volume: 1.06 k
|
4:01 PM EDT May 17, 2013
|
|
|
|
|
|
|
|
| 6:00 AM
|
CombiMatrix Corporation Reports Results for 2013 First Quarter
- Globe Newswire
|
|
|
| 6:00 AM
|
CombiMatrix Executes Equity Financing
- Globe Newswire
|
|
|
| 6:00 AM
|
CombiMatrix Corporation to Release First Quarter Financial Results on May 8, 2013
- Globe Newswire
|
|
|
| 8:45 AM
|
Free Research Reports on CBMX, CPWR, RVBD and TEX Issued by the Bedford Report
- Marketwired
|
|
|
| 6:00 AM
|
CombiMatrix Reports Preliminary Quarterly Growth in Prenatal Testing Volumes of 124% for First Quarter
- Globe Newswire
|
|
|
| 8:15 AM
|
Free Research Reports on CBMX, OPXA, PTEK and ZIOP Issued by the Bedford Report
- Marketwired
|
|
|
| 9:00 AM
|
CombiMatrix Announces $2 Million Registered Direct Offering
- Globe Newswire
|
|
|
| 8:00 AM
|
New Assays, Enhanced Solutions Drive Momentum - Research Report on Quest Diagnostics, Life Technologies, LabCorp, Health Net, and CombiMatrix
- PR Newswire
|
|
|
| 6:00 AM
|
CombiMatrix Corporation Reports Results for 2012 Fourth Quarter
- Globe Newswire
|
|
|
| 8:19 AM
|
InvestorsGuru.com Filtered Mid-Day Market Movers Recap
- Investors Guru
|
|
|
| 8:15 AM
|
Free Research Reports on ARUN, BLOX, CBMX and WIFI Issued by the Bedford Report
- Marketwired
|
| 8:00 AM
|
Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
- PR Newswire
|
|
|
| 6:00 AM
|
Mark McDonough to Assume CEO Role at CombiMatrix
- Globe Newswire
|
|
|
| 6:00 AM
|
CombiMatrix Corporation to Release Fourth Quarter and Year-End Financial Results on February 27, 2013
- Globe Newswire
|
|
|
| 8:00 AM
|
The Real Story Behind ZGNX, GERN, FTR and CBMX
- Marketwired
|
|
|
| 8:00 AM
|
Perfect Trade Setups, How to Play PPHM, VVUS, MDCI and CBMX
- Marketwired
|
|
|
| 6:00 AM
|
CombiMatrix Reports Preliminary Annual Growth in Prenatal Testing Volumes of 172% and 171% for Fourth Quarter and Year, Respectively
- Globe Newswire
|
|
|
| 6:00 AM
|
CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
- Globe Newswire
|
|
|
| 8:25 AM
|
The Real Story Behind ZGNX, GERN, FTR and CBMX
- Marketwired
|
|
|
| 1:11 PM
|
Nasdaq Stocks Watch List: (NASDAQ: CBMX), (NASDAQ: GTIM)
- Accesswire
|
|
|
| 6:00 AM
|
NIH Studies in New England Journal of Medicine Favor Chromosomal Microarray Analysis Over Standard Karyotyping for Genetic Analysis
- Globe Newswire
|
|
|
| 4:00 PM
|
CombiMatrix Stockholders Approve Second Tranche of Series A Preferred Stock Financing; Announces 1-for-10 Reverse Split of Common Stock and Nasdaq-Listed Warrants
- Globe Newswire
|
|
|
| 6:00 AM
|
CombiMatrix to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum
- Globe Newswire
|
|
|
| 12:57 PM
|
CombiMatrix Appoints Jeremy M. Jones to Board of Directors
- Globe Newswire
|
|
|
| 6:00 AM
|
CombiMatrix Corporation Reports Results for 2012 Third Quarter
- Globe Newswire
|
|
|
|
|